These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37165308)

  • 1. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance.
    Cai X; Duan X; Tang T; Cui S; Wu T
    BMC Cancer; 2023 May; 23(1):423. PubMed ID: 37165308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS; Kolb EA; Mills CC; Sampson VB
    Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway.
    Cai X; Yu X; Tang T; Xu Y; Wu T
    Mol Carcinog; 2024 Sep; 63(9):1682-1696. PubMed ID: 38818897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
    Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Induced Microbubble Cavitation Combined with miR-34a-Loaded Nanoparticles for the Treatment of Castration-Resistant Prostate Cancer.
    Wang Z; Chen C; Tao Y; Zou P; Gao F; Jia C; Liu L; Li G; Zhang G; Duan Y; Shi Q
    J Biomed Nanotechnol; 2021 Jan; 17(1):78-89. PubMed ID: 33653498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
    Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
    Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
    Nakagawa T; Sato Y; Tanahashi T; Mitsui Y; Kida Y; Fujino Y; Hirata M; Kitamura S; Miyamoto H; Okamoto K; Muguruma N; Bando Y; Takayama T
    Gastric Cancer; 2020 May; 23(3):426-436. PubMed ID: 31677131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
    Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
    Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.
    Fu W; Hong Z; You X; Din J; Chen B; Zhao B; Yuan G; Li Q
    Biomed Pharmacother; 2019 Oct; 118():109374. PubMed ID: 31545228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.
    Park SE; Kim HG; Kim DE; Jung YJ; Kim Y; Jeong SY; Choi EK; Hwang JJ; Kim CS
    Invest New Drugs; 2018 Apr; 36(2):195-205. PubMed ID: 29110173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Xu W; Jiang K; Shen M; Chen Y; Huang HY
    Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
    Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
    Li Y; Wang Y; Xie Z; Hu H
    Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis.
    Cao H; Wang D; Sun P; Chen L; Feng Y; Gao R
    Aging (Albany NY); 2021 Oct; 13(19):23096-23107. PubMed ID: 34613933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
    Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.